✦ LIBER ✦

P03-365 - Venlafaxine and CYP2D6 in clinical practice: work in progress

✍ Scribed by P. Zeppegno; R. Rolla; V. Dalò; F. Ressico; A. Parafioriti; P. Prosperini; M. Vidali; G. Bellomo; E. Torre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P02-455 - Venlafaxine and CYP2D6 in clin

✍ Zeppegno, P.; Rolla, R.; Dalo, V.; Ressico, F.; Parafioriti, A.; Prosperini, P.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 12 KB

Personalized medicine in breast cancer:

✍ Ruddy, Kathryn J.; Desantis, Stephen D.; Gelman, Rebecca S.; Wu, Alan H. B.; Pun 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 237 KB

P03-361 - Determination of CYP2C19 and C

✍ M. Nascimento; D. Berge; A. Mané; J. Hernández; A. Merino; A. Bulbena 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 28 KB

Towards the implementation of CYP2D6 and

✍ Müller, Daniel J.; Kekin, Ivana; Kao, Amy C. C.; Brandl, Eva J. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 153 KB

P.2.c.031 Genotypic and phenotypic CYP2D

✍ C. Kane; A. Nichols; V. Chhaya; G. Buckley; C. Guico-Pabia 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

P.2.c.037 Assessing the pharmacokinetics

✍ C. Kane; A. Nichols; K. Focht; Q. Jiang; S. Preskorn; M. Burczynski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 107 KB